Qvt Financial LP Roivant Sciences Ltd. Call Options Transaction History
Qvt Financial LP
- $951 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
337Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$721 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$536 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$475 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$419 Million0.03% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$412 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.21B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...